Stellar Biotechnologies competitorsClear all

Stellar Biotechnologies's top competitors include Biogen, MyoKardia, Ironwood Pharmaceuticals and Vertex Pharmaceuticals.
Stellar Biotechnologies
Stellar Biotechnologies
Stellar Biotechnologies, Inc. specializes in Keyhole Limpet Hemocyanin protein and is focused in the rapidly-evolving field of immunotherapy.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Founding Date
Founding Date
1999
Founding Date
1978
Founding Date
2012
Founding Date
N/A
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Port Hueneme, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
Boston, US HQ
Employees
Employees
259% increase
Employees
7,8007% increase
Employees
1024% increase
Employees
51529% decrease
Employees
2,5009% increase
Valuation ($)
Valuation ($)
5.6 m
Valuation ($)
44.3 b
Valuation ($)
2.2 b
Valuation ($)
1.7 b
Valuation ($)
44.3 b
Twitter followers
Twitter followers
233
Twitter followers
26.4 k
Twitter followers
619
Twitter followers
3.5 k
Twitter followers
51.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
24.9
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
47.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
60%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
1015398
Alexa Website Rank
83540
Alexa Website Rank
337057
Alexa Website Rank
977640
Alexa Website Rank
562892

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$346.6m (FY, 2018)
Revenue (est.)
$3b (FY, 2018)
Net income
Net income
N/A
Net income
$3.7b (FY, 2016)
Net income
($67.7m) (FY, 2018)
Net income
($282.4m) (FY, 2018)
Net income
$2.1b (FY, 2018)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 24.3m
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 609m
Total funding raised
$ 2.4m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
515↓ 29% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
Vertex Pharmaceuticals
HQ
Boston, US
Employees
2,500↑ 9% increase

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company